ioMicroglia: Revolutionizing Neurodegenerative Disease Drug Development

Time: 4:00 pm
day: Day One


  • See characterisation and functional data on precision reprogrammed hiPSC-derived ioMicroglia that show phagocytosis and cytokine secretion within days, enabling consistent, rapid and physiologically relevant results
  • Discover how ioDisease models for late-onset Alzheimer’s allow precise identification of disease-related effects when compared with genetically matched ioWild Type Cells
  • Gain insights into CRISPR-Ready ioMicroglia, offering scalable and consistent CRISPR screens for drug target discovery in physiologically relevant human cell types